M. Rewers et al., NEWBORN SCREENING FOR HLA MARKERS ASSOCIATED WITH IDDM - DIABETES AUTOIMMUNITY STUDY IN THE YOUNG (DAISY), Diabetologia, 39(7), 1996, pp. 807-812
Citations number
22
Categorie Soggetti
Endocrynology & Metabolism","Medicine, General & Internal
Autoimmunity causing insulin-dependent diabetes mellitus (IDDM) begins
in early childhood due to interactions between genes and unknown envi
ronmental factors that may be identified through follow-up of a large
cohort of genetically susceptible children. Such a cohort has been est
ablished using a simple and rapid cord blood screening for HLA alleles
. The DRB1 and DQB1 second exon sequences were co-amplified using the
polymerase chain reaction and hybridized with single and pooled sequen
ce-specific oligonucleotide probes. Four individual probes were used t
o detect the susceptibility alleles DRB103, DRB1*04, and DQB1*0302 as
well as the usually protective DRB115/16 (DR2) alleles. In addition,
pooled probes allow the distinction of DR3/3 from the DR3/x genotype
(where x is neither DR2, 3, nor 4) and DR4/4 from DR4/x. Among 5000 ne
wborns from the general Denver population, we have found the high-risk
genotype (DRB103/DRB1*04, DQB1*0302) to be present in 2.4% of non-Hi
spanic whites, 2.8% of Hispanics, and 1.6% of African Americans. The m
oderate-risk genotypes (DRB104, DQB1*0302/DRB1*04, DQB1*0302, DRB1*04
, DQB10302/x, or DRB1*03/DRB1*03) are present in 17% of American non-
Hispanic whites, 24% of Hispanics and in 10% of African Americans. The
se results demonstrate the feasibility of a large-scale newborn screen
ing for genes associated with IDDM. The ultimate role for such a scree
ning in future routine prediction and prevention of IDDM will depend o
n the availability of an effective and acceptable form of clinical int
ervention.